Voxelotor Patent Expiration
Voxelotor is Used for increasing hemoglobin levels and treating sickle cell disease by administering Voxelotor orally to patients. It was first introduced by Global Blood Therapeutics Inc
Voxelotor Patents
Given below is the list of patents protecting Voxelotor, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Oxbryta | US10493035 | Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | Oct 12, 2037 | Global Blood Theraps |
| Oxbryta | US11020382 | Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | Dec 02, 2036 | Global Blood Theraps |
| Oxbryta | US11944612 | Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | Dec 02, 2036 | Global Blood Theraps |
| Oxbryta | US10722502 | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | Feb 06, 2035 | Global Blood Theraps |
| Oxbryta | US11452720 | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | Feb 06, 2035 | Global Blood Theraps |
| Oxbryta | US9447071 | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | Feb 06, 2035 | Global Blood Theraps |
| Oxbryta | US9248199 | 1:1 adducts of sickle hemoglobin | Jan 29, 2034 | Global Blood Theraps |
| Oxbryta | US9018210 | Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation | Nov 25, 2033 | Global Blood Theraps |
| Oxbryta | US10017491 | Compounds and uses thereof for the modulation of hemoglobin | Dec 28, 2032 | Global Blood Theraps |
| Oxbryta | US10034879 | Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation | Dec 28, 2032 | Global Blood Theraps |
| Oxbryta | US10806733 | Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation | Dec 28, 2032 | Global Blood Theraps |
Voxelotor's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List